Incruse Ellipta Dosage
Generic name: UMECLIDINIUM BROMIDE 62.5ug
Dosage form: aerosol, powder
Medically reviewed on October 20, 2017.
INCRUSE ELLIPTA (umeclidinium 62.5 mcg) should be administered as 1 inhalation once daily by the orally inhaled route only.
INCRUSE ELLIPTA should be used at the same time every day. Do not use INCRUSE ELLIPTA more than 1 time every 24 hours.
No dosage adjustment is required for geriatric patients, patients with renal impairment, or patients with moderate hepatic impairment [see Clinical Pharmacology (12.3)].
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Incruse Ellipta (umeclidinium)
- Incruse Ellipta Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 12 Reviews
- Drug class: anticholinergic bronchodilators
